SARS-CoV-2 isolate - hCoV-19/France/IDF-IPP17625/2023, lineage BA.2.86.1 / now updated to JN.5
virus

SARS-CoV-2 isolate - hCoV-19/France/IDF-IPP17625/2023, lineage BA.2.86.1 / now updated to JN.5

EVAg
Produced by
: IP
Shipping From
: Paris - FR

Product Description

Ref-SKU:
017V-05412
Infectious cell culture supernatant containing hCoV-19/France/IDF-IPP17625/2023, lineage BA.2.86.1 now updated to JN.5
Product Risk Group: 
RG3
ICTV Taxonomy: 
Riboviria / Orthornavirae / Pisuviricota / Pisoniviricetes / Nidovirales / Cornidovirineae / Coronaviridae / Orthocoronavirinae / Betacoronavirus / Sarbecovirus / Severe acute respiratory syndrome-related coronavirus
Virus name: 
SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2
Genotype: 
BA.2.86.1

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested and quantified
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
one vial

In stock

2 000,00 €
 (Cost per access for Academics)
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

GMO: 
No
Biosafety restrictions: 
Procedures BSL3
Virus host type: 
Human virus
Previous Name or Taxonomy: 
hCoV-19/France/IDF-IPP17625/2023
Viral titer: 
1E+6 PFU/mL
Production cell line: 
TMPRSS2-expressing VeroE6
Virus Cultivability: 
Cultivable virus
Passage: 
C2
Shipping conditions: 
Dry ice
IATA Classification: 
Category A, UN2814

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Monday, 21 August, 2023
Country of collection: 
France
Suspected epidemiological origin : 
France
Isolation host: 
Human (female)
Isolation technique: 
3 days in Vero E6-TMPRSS cell culture
Isolation conditions: 
MOI 10-4, 5% CO2 at 37°C